| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 08/03/2026 | ±2.9% | -0.2% | over-priced |
| 05/04/2026 | ±2.6% | +0.6% | over-priced |
| 11/03/2025 | ±1.6% | -0.5% | over-priced |
| 08/04/2025 | ±2.0% | -2.1% | under-priced |
| 05/05/2025 | ±2.5% | -2.8% | under-priced |
| 11/04/2024 | ±2.4% | +3.2% | under-priced |
| 08/05/2024 | ±2.2% | -1.8% | over-priced |
| 04/29/2024 | ±2.4% | +1.4% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q2 FY2026 | $3.48 | $116.0B | $14.9B |
| Q1 FY2026 | $1.00 | $85.1B | $4.5B |
| Q4 FY2025 | $1.54 | $82.3B | $6.6B |
| Q3 FY2025 | $1.76 | $85.3B | $7.8B |
ExxonMobil Holdings Corporation (XOM) reports in 73 days, with the next report estimated for 11/24/2026. Across the last 8 reports, options priced an average ±2.3% earnings move while the stock actually moved 1.6% on average — the market has been roughly fair on XOM's earnings risk. Fundamentals into the print: EPS up 112.2% year-over-year, revenue up 42.3%. QuantLogix's live 5-factor engine currently reads XOM as a buy at 81/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →